Senseonics' CGM systems, Eversense ® and Eversense ® XL, include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor.

Trinity Biotech plc TRIB announced compelling positive clinical trial results with respect to its next-generation continuous glucose monitoring (CGM) technology, CGM+, on Tuesday. The trial data ...

Clinical data confirms elimination of requirement for finger-stick calibration, de-risking pathway to commercialization for the company’s next-generation CGM+ biosensor platformDUBLIN, Aug. 12, 2025 ...

San Diego-based Dexcom said at the annual J.P. Morgan Healthcare Conference in San Francisco that it's first-gen product co-developed by Alphabet's Verily may never get launched in the U.S.

CGM systems are composed of three main pieces: the sensor itself, which changes glucose concentration in the body to an electrical signal; the transmitter, which conditions the signals and encodes ...

Bioengineered tissue maker Humacyte (NASDAQ:HUMA) and Senseonics (NYSE:SENS), a developer of continuous glucose monitoring (CGM) devices, traded higher on Wednesday after Barclays initiated their ...

The FDA has approved extending the use of an implantable continuous glucose monitoring sensor for up to 6 months for adults with diabetes, according to a company press release. Senseonics’s ...

Senseonics' CGM Systems, Eversense ® and Eversense ® XL, include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor.

DexCom, Inc. DXCM recently unveiled new data for its upcoming G7 15-day continuous glucose monitoring (CGM) sensor at the Advanced Technologies & Treatments for Diabetes (ATTD) conference 2025 ...

As Healio previously reported, the Dexcom G7 CGM was cleared in December 2022 for people aged 2 years and older with type 1 and type 2 diabetes. Each sensor for the current-generation device can ...

Belgian startup Indigo Diabetes scores €38 million to develop its under the skin CGM sensor The company is looking to test the product in the US and Europe, with the goal of gaining market approval ...

Abbott recently launched the FreeStyle Libre 3 Plus sensor, which it says is the smallest and most discreet sensor on the market. It will soon be available in U.S. retail pharmacies and medical ...